APO Research
Talk to an analyst

APO RESEARCH · REPORT

Competent Cells

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Selected research

Market Structure

Global Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchCompetent Cells Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Competent Cells Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Competent Cells Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Competent Cells Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.

North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.

Read the full market overview

In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.

Report Includes

This report provides an overview of the global Competent Cells market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Competent Cells and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Competent Cells revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Competent Cells market size, projected growth trends, production technologies, key applications, and end-use industries.

Competent Cells Segment by Company

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N.V.

OriGene Technologies

Lucigen

Zymo Research

Bio-Rad Laboratories

Bioline

Delphi Genetics

IBA GmBH

Cell Applications

BioDynamics Laboratory

Scarab Genomics

GCC Biotech

SMOBIO Technology

Edge BioSystems

Competent Cells Segment by Type

Chemically Competent Cells

Electrocompetent Cells

Competent Cells Segment by Application

Subcloning & Routine Cloning

Phage Display Library Construction

Toxic/Unstable DNA Cloning

High-Throughput Cloning

Protein Expression

Mutagenesis

Single-Stranded DNA Production

Bacmid Creation

Cre-Lox Recombination (PIR1/PIR2)

Competent Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Competent Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Competent Cells industry.

Chapter 3: Detailed analysis of Competent Cells companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Competent Cellsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Chemically Competent Cells Table 3. Key Players of Electrocompetent Cells Table 4. Global Competent Cells Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Subcloning & Routine Cloning Table 6. Key Players of Phage Display Library Construction Table 7. Key Players of Toxic/Unstable DNA Cloning Table 8. Key Players of High-Throughput Cloning Table 9. Key Players of Protein Expression Table 10. Key Players of Mutagenesis Table 11. Key Players of Single-Stranded DNA Production Table 12. Key Players of Bacmid Creation Table 13. Key Players of Cre-Lox Recombination (PIR1/PIR2) Table 14. Global Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Competent Cells Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Competent Cells Market Share by Region (2021-2026) Table 17. Global Competent Cells Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Competent Cells Market Share by Region (2027-2032) Table 19. Competent Cells Industry Trends Table 20. Competent Cells Industry Drivers Table 21. Competent Cells Industry Opportunities and Challenges Table 22. Competent Cells Industry Restraints Table 23. Global Competent Cells Revenue by Company (US$ Million) & (2021-2026) Table 24. Global Competent Cells Revenue Market Share by Company (2021-2026) Table 25. Global Competent Cells Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 26. Global Competent Cells Key Company Head Office and Area Served Table 27. Global Competent Cells Company, Product Type & Application Table 28. Global Competent Cells Company Establishment Date Table 29. Global Company Market Concentration Ratio (CR5 and HHI) Table 30. Global Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 31. Global Competent Cells Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Competent Cells Market Size by Type (2021-2026) & (US$ Million) Table 33. Global Competent Cells Market Size by Type (2027-2032) & (US$ Million) Table 34. Global Competent Cells Revenue Market Share by Type (2021-2026) Table 35. Global Competent Cells Revenue Market Share by Type (2027-2032) Table 36. Global Competent Cells Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Competent Cells Market Size by Application (2021-2026) & (US$ Million) Table 38. Global Competent Cells Market Size by Application (2027-2032) & (US$ Million) Table 39. Global Competent Cells Revenue Market Share by Application (2021-2026) Table 40. Global Competent Cells Revenue Market Share by Application (2027-2032) Table 41. Merck KGaA Company Information Table 42. Merck KGaA Business Overview Table 43. Merck KGaA Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Merck KGaA Competent Cells Product Portfolio Table 45. Merck KGaA Recent Development Table 46. Thermo Fisher Scientific Company Information Table 47. Thermo Fisher Scientific Business Overview Table 48. Thermo Fisher Scientific Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Thermo Fisher Scientific Competent Cells Product Portfolio Table 50. Thermo Fisher Scientific Recent Development Table 51. Agilent Technologies Company Information Table 52. Agilent Technologies Business Overview Table 53. Agilent Technologies Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Agilent Technologies Competent Cells Product Portfolio Table 55. Agilent Technologies Recent Development Table 56. Takara Bio Company Information Table 57. Takara Bio Business Overview Table 58. Takara Bio Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Takara Bio Competent Cells Product Portfolio Table 60. Takara Bio Recent Development Table 61. Promega Corporation Company Information Table 62. Promega Corporation Business Overview Table 63. Promega Corporation Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Promega Corporation Competent Cells Product Portfolio Table 65. Promega Corporation Recent Development Table 66. Beijing TransGen Biotech Company Information Table 67. Beijing TransGen Biotech Business Overview Table 68. Beijing TransGen Biotech Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Beijing TransGen Biotech Competent Cells Product Portfolio Table 70. Beijing TransGen Biotech Recent Development Table 71. GeneScript Corporation Company Information Table 72. GeneScript Corporation Business Overview Table 73. GeneScript Corporation Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. GeneScript Corporation Competent Cells Product Portfolio Table 75. GeneScript Corporation Recent Development Table 76. Yeastern Biotech Company Information Table 77. Yeastern Biotech Business Overview Table 78. Yeastern Biotech Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Yeastern Biotech Competent Cells Product Portfolio Table 80. Yeastern Biotech Recent Development Table 81. New England Biolabs Company Information Table 82. New England Biolabs Business Overview Table 83. New England Biolabs Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. New England Biolabs Competent Cells Product Portfolio Table 85. New England Biolabs Recent Development Table 86. QIAGEN N.V. Company Information Table 87. QIAGEN N.V. Business Overview Table 88. QIAGEN N.V. Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. QIAGEN N.V. Competent Cells Product Portfolio Table 90. QIAGEN N.V. Recent Development Table 91. OriGene Technologies Company Information Table 92. OriGene Technologies Business Overview Table 93. OriGene Technologies Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. OriGene Technologies Competent Cells Product Portfolio Table 95. OriGene Technologies Recent Development Table 96. Lucigen Company Information Table 97. Lucigen Business Overview Table 98. Lucigen Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Lucigen Competent Cells Product Portfolio Table 100. Lucigen Recent Development Table 101. Zymo Research Company Information Table 102. Zymo Research Business Overview Table 103. Zymo Research Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Zymo Research Competent Cells Product Portfolio Table 105. Zymo Research Recent Development Table 106. Bio-Rad Laboratories Company Information Table 107. Bio-Rad Laboratories Business Overview Table 108. Bio-Rad Laboratories Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Bio-Rad Laboratories Competent Cells Product Portfolio Table 110. Bio-Rad Laboratories Recent Development Table 111. Bioline Company Information Table 112. Bioline Business Overview Table 113. Bioline Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Bioline Competent Cells Product Portfolio Table 115. Bioline Recent Development Table 116. Delphi Genetics Company Information Table 117. Delphi Genetics Business Overview Table 118. Delphi Genetics Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Delphi Genetics Competent Cells Product Portfolio Table 120. Delphi Genetics Recent Development Table 121. IBA GmBH Company Information Table 122. IBA GmBH Business Overview Table 123. IBA GmBH Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. IBA GmBH Competent Cells Product Portfolio Table 125. IBA GmBH Recent Development Table 126. Cell Applications Company Information Table 127. Cell Applications Business Overview Table 128. Cell Applications Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Cell Applications Competent Cells Product Portfolio Table 130. Cell Applications Recent Development Table 131. BioDynamics Laboratory Company Information Table 132. BioDynamics Laboratory Business Overview Table 133. BioDynamics Laboratory Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. BioDynamics Laboratory Competent Cells Product Portfolio Table 135. BioDynamics Laboratory Recent Development Table 136. Scarab Genomics Company Information Table 137. Scarab Genomics Business Overview Table 138. Scarab Genomics Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Scarab Genomics Competent Cells Product Portfolio Table 140. Scarab Genomics Recent Development Table 141. GCC Biotech Company Information Table 142. GCC Biotech Business Overview Table 143. GCC Biotech Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 144. GCC Biotech Competent Cells Product Portfolio Table 145. GCC Biotech Recent Development Table 146. SMOBIO Technology Company Information Table 147. SMOBIO Technology Business Overview Table 148. SMOBIO Technology Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 149. SMOBIO Technology Competent Cells Product Portfolio Table 150. SMOBIO Technology Recent Development Table 151. Edge BioSystems Company Information Table 152. Edge BioSystems Business Overview Table 153. Edge BioSystems Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 154. Edge BioSystems Competent Cells Product Portfolio Table 155. Edge BioSystems Recent Development Table 156. North America Competent Cells Market Size by Type (2021-2026) & (US$ Million) Table 157. North America Competent Cells Market Size by Type (2027-2032) & (US$ Million) Table 158. North America Competent Cells Market Size by Application (2021-2026) & (US$ Million) Table 159. North America Competent Cells Market Size by Application (2027-2032) & (US$ Million) Table 160. North America Competent Cells Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. North America Competent Cells Market Size by Country (2021-2026) Table 162. North America Competent Cells Market Size by Country (2027-2032) Table 163. Europe Competent Cells Market Size by Type (2021-2026) & (US$ Million) Table 164. Europe Competent Cells Market Size by Type (2027-2032) & (US$ Million) Table 165. Europe Competent Cells Market Size by Application (2021-2026) & (US$ Million) Table 166. Europe Competent Cells Market Size by Application (2027-2032) & (US$ Million) Table 167. Europe Competent Cells Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Competent Cells Market Size by Country (2021-2026) Table 169. Europe Competent Cells Market Size by Country (2027-2032) Table 170. China Competent Cells Market Size by Type (2021-2026) & (US$ Million) Table 171. China Competent Cells Market Size by Type (2027-2032) & (US$ Million) Table 172. China Competent Cells Market Size by Application (2021-2026) & (US$ Million) Table 173. China Competent Cells Market Size by Application (2027-2032) & (US$ Million) Table 174. Asia Competent Cells Market Size by Type (2021-2026) & (US$ Million) Table 175. Asia Competent Cells Market Size by Type (2027-2032) & (US$ Million) Table 176. Asia Competent Cells Market Size by Application (2021-2026) & (US$ Million) Table 177. Asia Competent Cells Market Size by Application (2027-2032) & (US$ Million) Table 178. Asia Competent Cells Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Competent Cells Market Size by Country (2021-2026) Table 180. Asia Competent Cells Market Size by Country (2027-2032) Table 181. South America, Middle East & Africa Competent Cells Market Size by Type (2021-2026) & (US$ Million) Table 182. South America, Middle East & Africa Competent Cells Market Size by Type (2027-2032) & (US$ Million) Table 183. South America, Middle East & Africa Competent Cells Market Size by Application (2021-2026) & (US$ Million) Table 184. South America, Middle East & Africa Competent Cells Market Size by Application (2027-2032) & (US$ Million) Table 185. South America, Middle East & Africa Competent Cells Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. South America, Middle East & Africa Competent Cells Market Size by Country (2021-2026) Table 187. South America, Middle East & Africa Competent Cells Market Size by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Competent Cells Product Image Figure 2. Global Competent Cells Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Competent Cells Market Share by Type: 2025 VS 2032 Figure 4. Chemically Competent Cells Image Figure 5. Electrocompetent Cells Image Figure 6. Global Competent Cells Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Competent Cells Market Share by Application: 2025 VS 2032 Figure 8. Subcloning & Routine Cloning Image Figure 9. Phage Display Library Construction Image Figure 10. Toxic/Unstable DNA Cloning Image Figure 11. High-Throughput Cloning Image Figure 12. Protein Expression Image Figure 13. Mutagenesis Image Figure 14. Single-Stranded DNA Production Image Figure 15. Bacmid Creation Image Figure 16. Cre-Lox Recombination (PIR1/PIR2) Image Figure 17. Global Competent Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Competent Cells Market Size (2021-2032) & (US$ Million) Figure 19. Global Competent Cells Market Share by Region: 2025 VS 2032 Figure 20. Years Considered Figure 21. Global Competent Cells Market Share by Players in 2025 Figure 22. Global Top 5 and 10 Competent Cells Players Market Share by Revenue in 2025 Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Competent Cells Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Competent Cells Revenue Market Share by Type (2021-2032) Figure 26. Global Competent Cells Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Competent Cells Revenue Market Share by Application (2021-2032) Figure 28. North America Competent Cells Market Size (2021-2032) & (US$ Million) Figure 29. North America Competent Cells Market Share by Type (2021-2032) Figure 30. North America Competent Cells Market Share by Application (2021-2032) Figure 31. North America Competent Cells Market Share by Country (2021-2032) Figure 32. United States Competent Cells Market Size (2021-2032) & (US$ Million) Figure 33. Canada Competent Cells Market Size (2021-2032) & (US$ Million) Figure 34. Mexico Competent Cells Market Size (2021-2032) & (US$ Million) Figure 35. Europe Competent Cells Market Size (2021-2032) & (US$ Million) Figure 36. Europe Competent Cells Market Share by Type (2021-2032) Figure 37. Europe Competent Cells Market Share by Application (2021-2032) Figure 38. Europe Competent Cells Market Share by Country (2021-2032) Figure 39. Germany Competent Cells Market Size (2021-2032) & (US$ Million) Figure 40. France Competent Cells Market Size (2021-2032) & (US$ Million) Figure 41. U.K. Competent Cells Market Size (2021-2032) & (US$ Million) Figure 42. Italy Competent Cells Market Size (2021-2032) & (US$ Million) Figure 43. Russia Competent Cells Market Size (2021-2032) & (US$ Million) Figure 44. Nordic Countries Competent Cells Market Size (2021-2032) & (US$ Million) Figure 45. China Competent Cells Market Size (2021-2032) & (US$ Million) Figure 46. China Competent Cells Market Share by Type (2021-2032) Figure 47. China Competent Cells Market Share by Application (2021-2032) Figure 48. Asia Competent Cells Market Size (2021-2032) & (US$ Million) Figure 49. Asia Competent Cells Market Share by Type (2021-2032) Figure 50. Asia Competent Cells Market Share by Application (2021-2032) Figure 51. Asia Competent Cells Market Share by Country (2021-2032) Figure 52. Japan Competent Cells Market Size (2021-2032) & (US$ Million) Figure 53. South Korea Competent Cells Market Size (2021-2032) & (US$ Million) Figure 54. Taiwan Competent Cells Market Size (2021-2032) & (US$ Million) Figure 55. Southeast Asia Competent Cells Market Size (2021-2032) & (US$ Million) Figure 56. India Competent Cells Market Size (2021-2032) & (US$ Million) Figure 57. Australia Competent Cells Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Competent Cells Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Competent Cells Market Share by Type (2021-2032) Figure 60. South America, Middle East & Africa Competent Cells Market Share by Application (2021-2032) Figure 61. South America, Middle East & Africa Competent Cells Market Share by Country (2021-2032) Figure 62. Brazil Competent Cells Market Size (2021-2032) & (US$ Million) Figure 63. South Africa Competent Cells Market Size (2021-2032) & (US$ Million) Figure 64. Saudi Arabia Competent Cells Market Size (2021-2032) & (US$ Million) Figure 65. Turkey Competent Cells Market Size (2021-2032) & (US$ Million) Figure 66. Argentina Competent Cells Market Size (2021-2032) & (US$ Million) Figure 67. UAE Competent Cells Market Size (2021-2032) & (US$ Million) Figure 68. Egypt Competent Cells Market Size (2021-2032) & (US$ Million) Figure 69. Chile Competent Cells Market Size (2021-2032) & (US$ Million) Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Chemically Competent Cells
  • Electrocompetent Cells
Applications
  • Subcloning & Routine Cloning
  • Phage Display Library Construction
  • Toxic/Unstable DNA Cloning
  • High-Throughput Cloning
  • Protein Expression
  • Mutagenesis
  • Single-Stranded DNA Production
  • Bacmid Creation
  • Cre-Lox Recombination (PIR1/PIR2)
Companies covered
  • Merck KGaA
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Takara Bio
  • Promega Corporation
  • Beijing TransGen Biotech
  • GeneScript Corporation
  • Yeastern Biotech
  • New England Biolabs
  • QIAGEN N.V.
  • OriGene Technologies
  • Lucigen
  • Zymo Research
  • Bio-Rad Laboratories
  • Bioline
  • Delphi Genetics
  • IBA GmBH
  • Cell Applications
  • BioDynamics Laboratory
  • Scarab Genomics
  • GCC Biotech
  • SMOBIO Technology
  • Edge BioSystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Competent Cells Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Chemically Competent Cells
  5. 1.2.3 Electrocompetent Cells
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Competent Cells Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Subcloning & Routine Cloning
  9. 1.3.3 Phage Display Library Construction
  10. 1.3.4 Toxic/Unstable DNA Cloning
  11. 1.3.5 High-Throughput Cloning
  12. 1.3.6 Protein Expression
  13. 1.3.7 Mutagenesis
  14. 1.3.8 Single-Stranded DNA Production
  15. 1.3.9 Bacmid Creation
  16. 1.3.10 Cre-Lox Recombination (PIR1/PIR2)
  17. 1.4 Global Market Growth Prospects
  18. 1.5 Global Competent Cells Growth Trends by Region
  19. 1.5.1 Global Competent Cells Market Size by Region: 2021 VS 2025 VS 2032
  20. 1.5.2 Competent Cells Market Size by Region (2021-2026)
  21. 1.5.3 Competent Cells Market Size by Region (2027-2032)
  22. 1.6 Assumptions and Limitations
  23. 1.7 Study Goals and Objectives
  24. 1.8 Years Considered
2 Global Competent Cells Market Dynamics
  1. 2.1 Competent Cells Industry Trends
  2. 2.2 Competent Cells Industry Drivers
  3. 2.3 Competent Cells Industry Opportunities and Challenges
  4. 2.4 Competent Cells Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Competent Cells Revenue by Company (2021-2026)
  2. 3.2 Global Competent Cells Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Competent Cells Key Company Head office and Area Served
  4. 3.4 Global Competent Cells Company, Product Type & Application
  5. 3.5 Global Competent Cells Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Competent Cells Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Competent Cells Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Competent Cells Tier 1, Tier 2, and Tier 3
4 Competent Cells Market by Type
  1. 4.1 Global Competent Cells Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Competent Cells Market Size by Type (2021-2032)
  3. 4.3 Global Competent Cells Market Size Share by Type (2021-2032)
5 Competent Cells Market by Application
  1. 5.1 Global Competent Cells Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Competent Cells Market Size by Application (2021-2032)
  3. 5.3 Global Competent Cells Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck KGaA
  2. 6.1.1 Merck KGaA Company Information
  3. 6.1.2 Merck KGaA Business Overview
  4. 6.1.3 Merck KGaA Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck KGaA Competent Cells Product Portfolio
  6. 6.1.5 Merck KGaA Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 Agilent Technologies
  14. 6.3.1 Agilent Technologies Company Information
  15. 6.3.2 Agilent Technologies Business Overview
  16. 6.3.3 Agilent Technologies Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Agilent Technologies Competent Cells Product Portfolio
  18. 6.3.5 Agilent Technologies Recent Developments
  19. 6.4 Takara Bio
  20. 6.4.1 Takara Bio Company Information
  21. 6.4.2 Takara Bio Business Overview
  22. 6.4.3 Takara Bio Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Takara Bio Competent Cells Product Portfolio
  24. 6.4.5 Takara Bio Recent Developments
  25. 6.5 Promega Corporation
  26. 6.5.1 Promega Corporation Company Information
  27. 6.5.2 Promega Corporation Business Overview
  28. 6.5.3 Promega Corporation Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Promega Corporation Competent Cells Product Portfolio
  30. 6.5.5 Promega Corporation Recent Developments
  31. 6.6 Beijing TransGen Biotech
  32. 6.6.1 Beijing TransGen Biotech Company Information
  33. 6.6.2 Beijing TransGen Biotech Business Overview
  34. 6.6.3 Beijing TransGen Biotech Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
  36. 6.6.5 Beijing TransGen Biotech Recent Developments
  37. 6.7 GeneScript Corporation
  38. 6.7.1 GeneScript Corporation Company Information
  39. 6.7.2 GeneScript Corporation Business Overview
  40. 6.7.3 GeneScript Corporation Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GeneScript Corporation Competent Cells Product Portfolio
  42. 6.7.5 GeneScript Corporation Recent Developments
  43. 6.8 Yeastern Biotech
  44. 6.8.1 Yeastern Biotech Company Information
  45. 6.8.2 Yeastern Biotech Business Overview
  46. 6.8.3 Yeastern Biotech Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Yeastern Biotech Competent Cells Product Portfolio
  48. 6.8.5 Yeastern Biotech Recent Developments
  49. 6.9 New England Biolabs
  50. 6.9.1 New England Biolabs Company Information
  51. 6.9.2 New England Biolabs Business Overview
  52. 6.9.3 New England Biolabs Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 New England Biolabs Competent Cells Product Portfolio
  54. 6.9.5 New England Biolabs Recent Developments
  55. 6.10 QIAGEN N.V.
  56. 6.10.1 QIAGEN N.V. Company Information
  57. 6.10.2 QIAGEN N.V. Business Overview
  58. 6.10.3 QIAGEN N.V. Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 QIAGEN N.V. Competent Cells Product Portfolio
  60. 6.10.5 QIAGEN N.V. Recent Developments
  61. 6.11 OriGene Technologies
  62. 6.11.1 OriGene Technologies Company Information
  63. 6.11.2 OriGene Technologies Business Overview
  64. 6.11.3 OriGene Technologies Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 OriGene Technologies Competent Cells Product Portfolio
  66. 6.11.5 OriGene Technologies Recent Developments
  67. 6.12 Lucigen
  68. 6.12.1 Lucigen Company Information
  69. 6.12.2 Lucigen Business Overview
  70. 6.12.3 Lucigen Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Lucigen Competent Cells Product Portfolio
  72. 6.12.5 Lucigen Recent Developments
  73. 6.13 Zymo Research
  74. 6.13.1 Zymo Research Company Information
  75. 6.13.2 Zymo Research Business Overview
  76. 6.13.3 Zymo Research Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Zymo Research Competent Cells Product Portfolio
  78. 6.13.5 Zymo Research Recent Developments
  79. 6.14 Bio-Rad Laboratories
  80. 6.14.1 Bio-Rad Laboratories Company Information
  81. 6.14.2 Bio-Rad Laboratories Business Overview
  82. 6.14.3 Bio-Rad Laboratories Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
  84. 6.14.5 Bio-Rad Laboratories Recent Developments
  85. 6.15 Bioline
  86. 6.15.1 Bioline Company Information
  87. 6.15.2 Bioline Business Overview
  88. 6.15.3 Bioline Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Bioline Competent Cells Product Portfolio
  90. 6.15.5 Bioline Recent Developments
  91. 6.16 Delphi Genetics
  92. 6.16.1 Delphi Genetics Company Information
  93. 6.16.2 Delphi Genetics Business Overview
  94. 6.16.3 Delphi Genetics Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Delphi Genetics Competent Cells Product Portfolio
  96. 6.16.5 Delphi Genetics Recent Developments
  97. 6.17 IBA GmBH
  98. 6.17.1 IBA GmBH Company Information
  99. 6.17.2 IBA GmBH Business Overview
  100. 6.17.3 IBA GmBH Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 IBA GmBH Competent Cells Product Portfolio
  102. 6.17.5 IBA GmBH Recent Developments
  103. 6.18 Cell Applications
  104. 6.18.1 Cell Applications Company Information
  105. 6.18.2 Cell Applications Business Overview
  106. 6.18.3 Cell Applications Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Cell Applications Competent Cells Product Portfolio
  108. 6.18.5 Cell Applications Recent Developments
  109. 6.19 BioDynamics Laboratory
  110. 6.19.1 BioDynamics Laboratory Company Information
  111. 6.19.2 BioDynamics Laboratory Business Overview
  112. 6.19.3 BioDynamics Laboratory Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
  114. 6.19.5 BioDynamics Laboratory Recent Developments
  115. 6.20 Scarab Genomics
  116. 6.20.1 Scarab Genomics Company Information
  117. 6.20.2 Scarab Genomics Business Overview
  118. 6.20.3 Scarab Genomics Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Scarab Genomics Competent Cells Product Portfolio
  120. 6.20.5 Scarab Genomics Recent Developments
  121. 6.21 GCC Biotech
  122. 6.21.1 GCC Biotech Company Information
  123. 6.21.2 GCC Biotech Business Overview
  124. 6.21.3 GCC Biotech Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 GCC Biotech Competent Cells Product Portfolio
  126. 6.21.5 GCC Biotech Recent Developments
  127. 6.22 SMOBIO Technology
  128. 6.22.1 SMOBIO Technology Company Information
  129. 6.22.2 SMOBIO Technology Business Overview
  130. 6.22.3 SMOBIO Technology Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 SMOBIO Technology Competent Cells Product Portfolio
  132. 6.22.5 SMOBIO Technology Recent Developments
  133. 6.23 Edge BioSystems
  134. 6.23.1 Edge BioSystems Company Information
  135. 6.23.2 Edge BioSystems Business Overview
  136. 6.23.3 Edge BioSystems Competent Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Edge BioSystems Competent Cells Product Portfolio
  138. 6.23.5 Edge BioSystems Recent Developments
7 North America
  1. 7.1 North America Competent Cells Market Size (2021-2032)
  2. 7.2 North America Competent Cells Market Size by Type
  3. 7.2.1 North America Competent Cells Market Size by Type (2021-2026)
  4. 7.2.2 North America Competent Cells Market Size by Type (2027-2032)
  5. 7.2.3 North America Competent Cells Market Share by Type (2021-2032)
  6. 7.3 North America Competent Cells Market Size by Application
  7. 7.3.1 North America Competent Cells Market Size by Application (2021-2026)
  8. 7.3.2 North America Competent Cells Market Size by Application (2027-2032)
  9. 7.3.3 North America Competent Cells Market Share by Application (2021-2032)
  10. 7.4 North America Competent Cells Market Size by Country
  11. 7.4.1 North America Competent Cells Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Competent Cells Market Size by Country (2021-2026)
  13. 7.4.3 North America Competent Cells Market Size by Country (2027-2032)
  14. 7.4.4 North America Competent Cells Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Competent Cells Market Size (2021-2032)
  2. 8.2 Europe Competent Cells Market Size by Type
  3. 8.2.1 Europe Competent Cells Market Size by Type (2021-2026)
  4. 8.2.2 Europe Competent Cells Market Size by Type (2027-2032)
  5. 8.2.3 Europe Competent Cells Market Share by Type (2021-2032)
  6. 8.3 Europe Competent Cells Market Size by Application
  7. 8.3.1 Europe Competent Cells Market Size by Application (2021-2026)
  8. 8.3.2 Europe Competent Cells Market Size by Application (2027-2032)
  9. 8.3.3 Europe Competent Cells Market Share by Application (2021-2032)
  10. 8.4 Europe Competent Cells Market Size by Country
  11. 8.4.1 Europe Competent Cells Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Competent Cells Market Size by Country (2021-2026)
  13. 8.4.3 Europe Competent Cells Market Size by Country (2027-2032)
  14. 8.4.4 Europe Competent Cells Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Competent Cells Market Size (2021-2032)
  2. 9.2 China Competent Cells Market Size by Type
  3. 9.2.1 China Competent Cells Market Size by Type (2021-2026)
  4. 9.2.2 China Competent Cells Market Size by Type (2027-2032)
  5. 9.2.3 China Competent Cells Market Share by Type (2021-2032)
  6. 9.3 China Competent Cells Market Size by Application
  7. 9.3.1 China Competent Cells Market Size by Application (2021-2026)
  8. 9.3.2 China Competent Cells Market Size by Application (2027-2032)
  9. 9.3.3 China Competent Cells Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Competent Cells Market Size (2021-2032)
  2. 10.2 Asia Competent Cells Market Size by Type
  3. 10.2.1 Asia Competent Cells Market Size by Type (2021-2026)
  4. 10.2.2 Asia Competent Cells Market Size by Type (2027-2032)
  5. 10.2.3 Asia Competent Cells Market Share by Type (2021-2032)
  6. 10.3 Asia Competent Cells Market Size by Application
  7. 10.3.1 Asia Competent Cells Market Size by Application (2021-2026)
  8. 10.3.2 Asia Competent Cells Market Size by Application (2027-2032)
  9. 10.3.3 Asia Competent Cells Market Share by Application (2021-2032)
  10. 10.4 Asia Competent Cells Market Size by Country
  11. 10.4.1 Asia Competent Cells Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Competent Cells Market Size by Country (2021-2026)
  13. 10.4.3 Asia Competent Cells Market Size by Country (2027-2032)
  14. 10.4.4 Asia Competent Cells Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Competent Cells Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Competent Cells Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Competent Cells Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Competent Cells Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Competent Cells Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Competent Cells Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Competent Cells Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Competent Cells Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Competent Cells Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Competent Cells Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Competent Cells Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Competent Cells Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Competent Cells Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Competent Cells Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst